Skip to main content

Table 1 Baseline characteristics of the study patients

From: Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients

Variables HF subjects (n=179) Non-HF subjects (n=163) p *
Age (years) 70 (58–76) 68 (57–75) 0.479
Gender (M/F) 132/47 123/40 0.716
Diabetes (%) 35 51 0.002
Hypertension (%) 57 71 0.010
Obesity (%) 41 44 0.807
Waist circumference (cm) 101.8±12.9 102.9±9.8 0.315
BMI (kg/m2) 29.0 (26.5−33.1) 29.3 (27.3−31.8) 0.975
SBP (mmHg) 120 (110–140) 137 (130–149) < 0.001
DBP (mmHg) 70 (66–80) 85 (78–90) < 0.001
Glucose (mmol/L) 5.9 (5.2–7.3) 6.2 (5.4–7.9) 0.386
Total-cholesterol (mmol/L) 4.72±1.29 5.03±1.11 0.028
LDL-cholesterol (mmol/L) 2.94±1.00 3.09±0.88 0.222
HDL-cholesterol (mmol/L) 1.11 (0.95–1.31) 1.34 (1.16–1.55) < 0.001
Triglycerides (mmol/L) 1.35 (0.98–1.71) 1.50 (0.98–2.32) 0.008
FABP4 (μg/L) 29.1 (19.2−55.0) 24.2 (19.3−34.5) < 0.001
  1. Abbreviations: HF, heart failure; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, Low-Density Lipoprotein; HDL, High-Density Lipoprotein; FABP4, adipocyte fatty acid binding protein.
  2. The data are presented as the mean±SD or median (interquartile range), unless otherwise indicated.
  3. *ANOVA and x2 tests were used to compare the mean of quantitative variables or the frequency of qualitative traits between HF and non-HF groups of subjects.
  4. Log-transformed before analysis.